Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy.
Archin NM, Liberty AL, Kashuba AD, Choudhary SK, Kuruc JD, Crooks AM, Parker DC, Anderson EM, Kearney MF, Strain MC, Richman DD, Hudgens MG, Bosch RJ, Coffin JM, Eron JJ, Hazuda DJ, Margolis DM.
Archin NM, et al. Among authors: coffin jm.
Nature. 2012 Jul 25;487(7408):482-5. doi: 10.1038/nature11286.
Nature. 2012.
PMID: 22837004
Free PMC article.